Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-11-14
2006-11-14
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S204100, C530S300000
Reexamination Certificate
active
07135186
ABSTRACT:
Varicella zostervirus (VZV) inimunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid positions 12 to 235 (SEQ ID NO: 7) of thevaricella zostervirus protein VP26, to nucleic acids which encode these peptides and to the use of the peptides or nucleic acids for diagnosing an infection withvaricella zostervirus.
REFERENCES:
patent: 4686101 (1987-08-01), Ellis et al.
Davison et al, J. of General Virology, 1992, vol. 73, pp. 2709-2713.
Davison et al, J. of General Virology, 1986, vol. 67, pp. 1759-1816.
A.J. Davison et al., “J Gen. Virol., vol. 67”, The Complete DNA Sequence of Varicella-Zoster Virus, pp. 1759-1819, (1986).
D.R. Harper et al., “The Journal of Infectious Diseases”, vol. 159 No. 3, IgM and IgG Responses to Varicella-Zoster Virus p. 32/p. 36 Complex After Chickenpox and Zoster, Congenital and Subclinical Infections, and Vaccination, pp. 444-451, (Mar. 1989).
A. Fafai et al., “Virus Research”, vol. 15, Antigenic Cross-Reaction Between A Varicella-Zoster Virus Nucleocapsid Protein Encoded By Gene 40 And A Herpes Simplex Virus Nucleocapsid Protein, pp. 163-174 (1990).
M.D. Davison et al., “Identification of Genese Encoding Two Capsid Proteins (VP24 and VP26) of Herpes Simplex Virus Type 1”, J. Gen Virology, (1992), 73 pp. 2709-2713.
A.J. Davison et al., “The Complete DNA Sequence of Varicella Zoster Virus”, J. Gen. Virol 67, (1986), pp. 1759-1816.
Eickmann Markus
Gicklhorn Dorothee
Giesendorf Bernhard
Hauser Hans-Peter
Radsak Klaus
Dade Behring Marburg GmbH
Heller Ehrman LLP
Salimi Ali R.
LandOfFree
Varicella zoster virus (VZV) immunoreactive protein VP26 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Varicella zoster virus (VZV) immunoreactive protein VP26 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Varicella zoster virus (VZV) immunoreactive protein VP26 and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3655929